<DOC>
	<DOCNO>NCT02639819</DOCNO>
	<brief_summary>This single-arm , open-label , safety feasibility pilot study ɛ-aminocaproic acid ICH patient . Consecutive ICH volume hematoma volume le 30 mL ABC/2 method present within 3 hour symptom onset , meet inclusion criterion , without exclusion consent enrol . Subjects receive 5 gram intravenous ɛ-aminocaproic acid 1 hour , follow 1 mg/hour 23 hour . Comupted tomography ( CT ) head do 24 hour order follow hematoma size . Electrocardiogram , low extremity venous Doppler NIHSS also do 24 hour . The patient follow clinic 30-90 day post discharge functional status .</brief_summary>
	<brief_title>Management Intracerebral Hemorrhage With Aminocaproic Acid - Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Cerebral Hemorrhage</mesh_term>
	<mesh_term>Aminocaproic Acid</mesh_term>
	<criteria>1 . Age 1880 year 2 . Supratentorial ICH ≤ 30 mL volume see ≥ 2 slice 0.5 mm CT head 3 . IVH involve &lt; 50 % ipsilateral lateral ventricle allow 4 . Treatment initiate within 1 hour baseline CT 3 hour onset last know normal 1 . Baseline mRS ≥ 2 2 . Infratentorial hemorrhage ( brainstem/cerebellum ) 3 . Any supratentorial hemorrhage extend brainstem 4 . ICH &gt; 30 mL 5 . Patients undergo surgical evacuation 6 . Presenting outside 3 hour window 7 . Intraventricular extension &gt; 1/2 one lateral ventricle 8 . Intraventricular extension 3rd 4th ventricle , aqueduct involve &gt; 50 % ipsilateral lateral ventricle 9 . ICH due trauma 10 . ICH due aneurysm arteriovenous malformation 11 . ICH due underlie neoplasm infectious mass 12 . ICH due Warfarin oral intravenous anticoagulant 13. International normalization ratio &gt; 1.4 14 . Life expectancy &lt; 1 year ( prior ICH onset ) ; due cause . 15 . History recent ischemic stroke ( within past 3 month ) 16 . History deep vein thrombosis pulmonary embolism 17 . History recent myocardial infarction ( within past 3 month ) 18 . Known history hypercoagulable state 19 . History cancer 20 . Glomerular filtration rate &lt; 60 mL/min 21 . Received hemostatic therapy indication ( last 14 day ) 22 . Received investigational therapy last 90 day 23 . `` Do Not Resuscitate '' order place expect , advance directive could limit aggressive treatment measure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Intracerebral Hemorrhage</keyword>
	<keyword>Stroke</keyword>
	<keyword>Cerebrovascular</keyword>
</DOC>